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Abstract
This study aimed to investigate the association between serum levels of 25-hydroxyvitamin D [25(OH)D] and metabolic
syndrome along with its associated risk factors in Korean postmenopausal women. This study was performed using data
from the KNHANES 2008–2010 study and included 4,364 postmenopausal Korean women. Clinical and other objective
characteristics, seasonality, and presence of metabolic syndrome with its five components were evaluated and correlated
with the serum levels of 25(OH)D. Although no statistically significant associations were observed between the levels of
serum 25(OH)D and the prevalence of metabolic syndrome, the adjusted OR for elevated blood pressure, elevated
triglycerides (TGs), and reduced high-density lipoprotein cholesterol (HDL-C) showed tendency to decrease sequentially as
tertiles of serum 25(OH)D levels increased (p for trends = 0.066, 0.043, and 0.010, respectively). Women in the highest tertile
of serum 25(OH)D showed a significant decrease in the prevalence of elevated blood pressure, elevated TGs, and reduced
HDL-C as compared with those in the lowest tertile of serum 25(OH)D (p= 0.020, 0.014, and 0.002, respectively). Based on
these results, we consider that adequate serum levels of 25(OH)D in Korean postmenopausal women may not entirely
indicate a lower risk of developing metabolic syndrome. However, adequate serum levels of 25(OH)D are significantly
associated with a decrease in elevated blood pressure, elevated TGs, and reduced HDL-C levels in postmenopausal women.
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Introduction
Cardiovascular complications are the major causes of death in
postmenopausal women. This is important because approximately
95% of women in urban areas experience menopause for more
than one-third of their lives [1]. Since menopause is a risk factor
for cardiovascular disease, it should be viewed as one of the most
serious problems faced by women. When women experience
menopause, they should not only be aware of preexisting
cardiovascular risk factors, but they should also closely observe
their overall health to help prevent cardiovascular disease.
Metabolic syndrome is a clinical disorder characterized by the
co-occurrence of heterogeneous traits, including abdominal
obesity, hypertension, dyslipidemia (high triglycerides (TG) and
low high-density lipoprotein cholesterol (HDL-C) levels), and
impaired glucose tolerance [2]. It is a well-recognized cluster of
modifiable risk factors of cardiovascular disease and type 2
diabetes mellitus (DM) [3,4]. The number of individuals with
metabolic syndrome is increasing in Asia [5], especially due to the
increased consumption of a westernized diet and reduced physical
activity [4].
Evidence suggests that maintaining vitamin D levels might
provide protective effects against metabolic syndrome and its
sequelae [6]. The prevalence of metabolic syndrome is known to
increase during menopause; however, studies evaluating the
prevalence of metabolic syndrome and its association with serum
levels of vitamin D in postmenopausal women are lacking.
Therefore, managing metabolic syndrome and studying its risk
factors, particularly in postmenopausal women, is crucial for
improving health in this population. Since the serum levels of
vitamin D and the prevalence of metabolic syndrome vary by
ethnicity [7], it is important to study this association in
postmenopausal women in the Korean population.
The aim of this study was to evaluate the prevalence of vitamin
D deficiency and metabolic syndrome in postmenopausal Korean
women. Additionally, by grouping participants into tertiles based
on serum 25-hydroxyvitamin D [25-(OH)D] levels, we were able
to assess the effects of menopausal status on metabolic syndrome
and its associated factors among Korean postmenopausal women.
Methods
Study Population
This study was performed using data from the Korean National
Health and Nutrition Examination Survey (KNHANES) (2008–
2010 data), specifically data from the KNHANES IV survey (data
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from 2008 and 2009) and the KNHANES V survey (data from
2010), all performed by the Korean Ministry of Health and
Welfare. KNHANES IV and V were each conducted for 3 years
(2007–2009 and 2010–2012, respectively), using a rolling sampling
survey that involved a complex, stratified, multistage, probability-
cluster survey of a representative sample of the non-institutional-
ized civilian population in South Korea. Sampling units were
randomly selected, with 23 households from each primary
sampling unit, with 200 randomly selected sampling units, yielding
4600 households in 2008, whereas 192 sampling units were
randomly selected, with 20 households from each primary
sampling unit, yielding 3840 households in 2009 and 2010. The
survey was composed of three parts: a health interview survey, a
health examination survey, and a nutrition survey. Each survey
was conducted by specially trained interviewers. The interviewers
were not provided with any prior information regarding specific
participants before conducting the interviews. Participants pro-
vided written informed consent to participate in this survey, and
we received the data in anonymized form. The study was
approved by the Yonsei University Health System, Severance
Hospital, Institutional Review Board (4–2013–0393).
We excluded male participants and individuals who were
pregnant or had chronic liver or renal disease. In addition,
participants were excluded if they had not provided blood samples
for 25(OH)D, fasting plasma glucose (FPG), and lipid profiles
including TG and HDL-C; or had not completed the self-
reporting questions regarding district resident type, smoking,
alcohol consumption, physical activity, education level, occupa-
tion, income, diet, sampled seasonality, use of anti-hypertensive,
diabetic, or anti-dyslipidemic medications, and use of hormone
therapy (HT). We also excluded subjects who did not provide
anthropometric measurements, including blood pressure (BP;
systolic and diastolic, i.e., systolic BP [SBP] and diastolic BP
[DBP], respectively), height, weight, and waist circumference
(WC) as well as women who had undergone surgical menopause.
Eventually, 10,907 (6,543 premenopausal and 4,364 postmeno-
pausal women) women were classified based on the presence of
menopause, and 4,364 postmenopausal women were enrolled in
the present study.
Variable Measurements
Based on age, menopausal women were grouped into 6
categories. District residents were categorized as urban and rural.
Seoul (the capital city of Korea), its surrounding capital area
(Gyonggi), and six other metropolitan cities (Incheon, Daejeon,
Gwangju, Daegu, Busan, and Ulsan) were grouped as urban areas,
and the remaining regions of South Korea were grouped as rural
areas. People were classified as current smokers, if they had
smoked at least one cigarette per day during the previous
12 months. Alcohol consumption was evaluated and categorized
into two groups, depending on the history of drinking for the
previous 12 months. Based on the International Physical Activity
Questionnaire short-form scoring protocol, physical activity levels
were divided into three categories as low, moderate, and high [8].
Education level was classified into three categories based on the
educational background: (1) elementary school; (2) middle or high
school; and (3) college or university. Occupation was classified into
four categories; (1) people who work regularly in an office, (2)
people who usually work outdoors, (3) people who work on a farm
or in a fishing village, and (4) people who usually stay at home.
Household income was divided into quartiles according to the
mean household income per month (income per month/!number
of family members). The circumstances of oral intake were
classified into three groups to predict whether they had been
supplied with sufficient nutrition (both quantity and quality)
through their meals as follows: (1) insufficient quantity and quality
frequently, (2) insufficient quantity and quality occasionally, and
(3) sufficient quantity with diverse nutritional supplementations.
The seasons in which the blood samples were taken were classified
into four categories as follows: (1) spring: March to May, (2)
summer: June to August, (3) fall: September to November, and (4)
winter: December to February. The usage of HT was divided into
two categories as ‘‘ever’’ and ‘‘never’’ users.
Anthropometric measurements were performed. Height and
weight were measured with subjects wearing light clothing but
without shoes. Waist circumference was measured at the midpoint
between the lower costal margin and iliac crest at the end of
normal expiration. Blood pressure was measured in the sitting
position after resting for 10 min, twice with 5-min intervals, and
the average value in mmHg was used. Blood samples were
collected early in the morning after an overnight fast. Plasma
concentrations of glucose, TGs, and HDL-C were measured
following routine biochemical laboratory protocols. Serum
25(OH)D levels were determined by electrochemiluminescence
immunoassay using a Cobas autoanalyzer (Roche Diagnostics,
West Sussex, UK; intra- and interassay coefficient of variations
(CVs) ,8% and ,10%, respectively). All clinical analyses were
performed by the Neodin Medical Institute, a laboratory certified
by the Korean Ministry of Health and Welfare.
Criteria and Definitions
Menopause is defined as amenorrhea for 12 months following
the final menstrual period [9]. In our study, postmenopausal status
was defined as the self-reported cessation of menstruation for more
than 1 year, and we excluded women who had undergone a
hysterectomy or bilateral salpingo-oophorectomy (BSO).
Although there is no consensus regarding the optimal serum
levels of 25(OH)D, in order to compare the vitamin D status in
various age groups among postmenopausal women, we classified it
as deficiency, insufficiency, and sufficiency as follows. Based on
previous data, vitamin D deficiency was defined as serum
25(OH)D levels less than 20 ng/mL [10]; vitamin D insufficiency,
as $20 ng/mL to ,30 ng/mL; and vitamin D sufficiency, as $
30 ng/mL [11]. We also grouped the participants according to the
tertiles of 25(OH)D (group 1 as 3.070–14.890 ng/mL, group 2 as
14.900–20.969 ng/mL, and group 3 as 20.970–66.960 ng/mL) in
order to compare baseline characteristics and to examine the
relationship between vitamin D status and the prevalence of
metabolic syndrome along with the associated factors among the
groups.
Metabolic syndrome was defined as the presence of three or
more of the following: (1) abdominal obesity (waist circumference
$85 cm in women according to the Korean Society for the study
of Obesity), (2) elevated blood pressure (average systolic blood
pressure $130 mmHg or diastolic blood pressure $85 mmHg) or
currently undergoing treatment for hypertension, (3) elevated
serum triglycerides ($150 mg/dL) or current drug treatment for
high TGs, (4) reduced HDL cholesterol (,50 mg/dL) or current
drug treatment for low HDL-C, and (5) elevated fasting glucose
levels ($100 mg/dL) or current usage of hypoglycemic agents or
insulin [12].
Statistical Analysis
Data are presented as means [95% confidence interval (CI)] for
continuous variables and percentages for categorical variables
unless otherwise stated. The status of vitamin D, the prevalence of
metabolic syndrome according to age groups, and baseline
characteristics depending on serum vitamin D levels were
Vitamin D and Metabolic Syndrome in Postmenopause
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calculated using chi-square test (x2 test). For the analysis of
differences between the prevalence of metabolic syndrome and its
risk factors among the three groups with different vitamin D levels,
one-way analysis of variance (ANOVA) was used for continuous
data, and x2 test was used for categorical data.
After confirming that the values of serum levels of 25(OH)D
were normally distributed, the odds ratio (OR), p for trends for the
prevalence of metabolic syndrome along with its factors according
to the tertiles of serum 25(OH)D, and p-value for the prevalence of
metabolic syndrome with its associated factors between the lowest
and the highest tertiles of serum 25(OH)D were analyzed using
linear logistic regression. The covariates for the adjusted OR
calculation included age, seasonality, occupation, education,
alcohol, smoking, physical activity, and HT.
Data analysis was carried out using SPSS software (version 20;
SPSS, Chicago, IL), and p,0.05 was considered statistically
significant.
Results
Figures 1 and 2 show the vitamin D status and the prevalence of
metabolic syndrome in postmenopausal Korean women. Vitamin
D deficiency was dominant in the general South Korean
postmenopausal female population (62.1%). The prevalence of
vitamin D deficiency was the highest in a group of ,50 years and
the lowest in a group of 60–64 years, being 72.5% and 60.1%,
respectively (Figure 1). The prevalence of metabolic syndrome
increased from 10.8% in women from a group of ,50 years to
43.1% in a group of 65–69 years (Figure 2).
Table 1 shows the baseline characteristics of 4364 postmeno-
pausal women according to tertile groups of serum 25(OH). For
increasing serum 25(OH)D levels, the percentages of people living
in urban areas tended to decrease whereas people in rural area
increased (p,0.001); people with low physical activity showed
lower percentages of proportion in the higher tertiles, whereas
those with high physical activity tended to show higher percent-
ages of proportion (p,0.001). Moreover, subjects who worked
outdoors (farming or fishing) showed the highest proportions in the
highest tertiles of serum 25(OH)D, whereas those mostly working
indoors (office workers and housewives) showed the highest
proportions in the lowest tertiles of serum 25(OH)D (p,0.001).
Most importantly, people sampled in the spring or winter were
present in the highest proportions in the lowest tertiles of serum
25(OH)D, while those sampled in the summer or autumn had the
highest proportions in the highest tertiles of 25(OH)D (p,0.001).
The tertile groups according to the serum 25(OH)D levels were
compared in terms of metabolic syndrome and its risk factors
among postmenopausal women in Table 2. The values of SBP,
DBP, and TGs in the lowest tertile of serum 25(OH)D were
higher, and the value of HDL-C in the lowest tertile of serum
Figure 1. Vitamin D status according to age groups in postmenopausal women. The lowest portion of the graph represents vitamin D
deficiency; the middle portion, vitamin D insufficiency; and the highest portion, vitamin D sufficiency. Vitamin D deficiency was dominant in the
postmenopausal South Korean female population (62.1%). The prevalence of vitamin D deficiency was the highest in group of ,50 years, 72.5% and
the lowest in group of 60–64 years, 60.1%.
doi:10.1371/journal.pone.0089721.g001
Figure 2. Prevalence of metabolic syndrome in postmenopaus-
al women. The prevalence of metabolic syndrome increased from
10.8% in women younger than 50 years to 43.1% in those aged 65–
69 years.
doi:10.1371/journal.pone.0089721.g002
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25(OH)D was lower than those in the highest tertile of 25(OH)D,
and the differences were statistically significant (p=0.044, 0.020,
0.001, and 0.005, respectively). Elevated TGs and reduced HDL-
C also showed the highest statistically significant proportions in the
lowest tertile of 25(OH)D (p=0.031 and 0.004, respectively).
Age, season, occupation, education, alcohol, smoking, physical
activity, and HT-adjusted OR for metabolic syndrome and its
components were evaluated according to the serum levels of
25(OH)D, which was categorized into tertile groups (Table 3).
Among the three groups, as serum levels of 25(OH)D increased,
no statistically significant associations were shown with the
prevalence of metabolic syndrome (p for trends = 0.333).
However, when we examined the components of metabolic
syndrome, the OR for the prevalence of elevated BP, elevated
TGs, and reduced HDL-C showed a tendency to decrease as the
serum levels of 25(OH)D increased (p for trends = 0.066, 0.043,
and 0.010, respectively). Additionally, when the lowest and
highest tertiles of serum 25(OH)D were compared, statistical
significance was observed for the same components, i.e., elevated
BP, elevated TGs, and reduced HDL-C (p=0.020, 0.014, and
0.002, respectively).
Discussion
In this study, we investigated whether serum levels of 25(OH)D
have associations with the prevalence of metabolic syndrome along
with its risk factors in postmenopausal Korean women. In this
retrospective study, although the prevalence of metabolic syn-
drome in postmenopausal women tended to decrease as serum
levels of 25(OH)D increased, this association was not statistically
significant. However, we confirmed that higher serum levels of
25(OH)D were associated with a statistically significant decrease in
the prevalence of the components of metabolic syndrome, i.e.,
elevated BP, elevated TGs, and reduced HDL-C.
Several reports have demonstrated a significant inverse associa-
tion between serum25(OH)D levels and the prevalence ofmetabolic
syndrome [13–16]. However, other studies, similar to ours, have
observed a lack of association between serum levels of 25(OH)D and
metabolic syndrome. In a Korean study, no association was found
between vitamin D deficiency and the overall metabolic syndrome
risk [17]. In another study from South Africa, serum levels of
25(OH)Dwere not an independent predictor ofmetabolic syndrome
in Africans and Asian Indians [18].
Table 1. General characteristics of postmenopausal participants compared by vitamin D status (n = 4364).
Serum 25(OH)D
Group 1 (%) Group 2 (%) Group 3 (%) p-value
Number 1454 1456 1454
Residents district Urban 992 (68.2) 811 (55.7) 742 (51.0) ,0.001
Rural 462 (31.8) 645 (44.3) 712 (49.0)
Smoking Never 1307 (90.0) 1314 (90.4) 1338 (92.0) 0.351
Ever 24 (1.7) 26 (1.8) 19 (1.3)
Current 122 (8.4) 113 (7.8) 97 (6.7)
Alcohol consumption None 1238 (85.2) 1202 (82.7) 1219 (83.8) 0.190
Yes 215 (14.8) 251 (17.3) 235 (16.2)
Physical activity Low 1169 (80.6) 1125 (77.6) 1064 (73.3) ,0.001
Moderate 128 (8.8) 151 (10.4) 180 (12.4)
High 154 (10.6) 173 (11.9) 208 (14.3)
Education level Elementary 937 (64.6) 943 (65.1) 984 (67.9) 0.067
Middle/High 415 (28.6) 416 (28.7) 400 (27.6)
College/University 98 (6.8) 90 (6.2) 65 (4.5)
Occupation Office workers 88 (6.1) 72 (5.0) 42 (2.9) ,0.001
Salesmen 134 (9.3) 152 (10.5) 107 (7.4)
Farmers/Fishermen 278 (19.2) 389 (26.8) 513 (35.4)
Housewives 947 (65.4) 836 (57.7) 786 (54.3)
Income Low 325 (23.1) 352 (24.5) 378 (26.5) 0.521
(quartile/person) Medium-Low 365 (26.0) 363 (25.3) 358 (25.1)
Medium-High 356 (25.3) 375 (26.1) 349 (24.4)
High 360 (25.6) 347 (24.1) 343 (24.0)
Diet Frequent deficiency 79 (5.4) 68 (4.7) 68 (4.7) 0.857
Occasional deficiency 896 (61.6) 896 (61.5) 896 (61.6)
Enough 479 (32.9) 492 (33.8) 490 (33.7)
Seasonality Spring 532 (36.6) 356 (24.5) 181 (12.4) ,0.001
Summer 267 (18.4) 377 (25.9) 513 (35.3)
Autumn 242 (16.6) 378 (26.0) 544 (37.4)
Winter 413 (28.4) 345(23.7) 216 (14.9)
doi:10.1371/journal.pone.0089721.t001
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Several studies have examined the effects of menopause on
metabolic syndrome, showing varied age groups for peak
prevalence in diverse ethnicities. A higher prevalence of metabolic
syndrome has been reported in women, especially those aged more
than 50 years, as compared with men in a Korean study [19].
Another Korean study reported that the prevalence of metabolic
syndrome increased after menopause [20]. A study in the U.S.
demonstrated an increased risk of metabolic syndrome up to more
than 20% among postmenopausal women [21], while another
study from the U.S. demonstrated that postmenopausal status was
consistently associated with an increased risk for metabolic
syndrome, based on the National Health and Nutrition Exami-
nation Survey III [22]. Moreover, a study that examined the
prevalence of metabolic syndrome and its association with
hyperinsulinemia in the urban Korean population concluded that
the prevalence of metabolic syndrome increased with increasing
tertiles of insulin resistance [23]. However, to the best of our
knowledge, our study is the first to demonstrate the effect of serum
levels of 25(OH)D on metabolic syndrome among postmenopausal
Korean women based on KNHANES.
The major factors leading to the results observed in the present
study are the significant abnormalities in lipid profiles [5]. In our
study, the adjusted OR for elevated TGs and reduced HDL-C
decreased as the tertiles of serum 25(OH)D increased. In several
studies, TGs [24] are generally known to be elevated in
postmenopausal women as compared with premenopausal wom-
en, and the cardioprotective features in women are known to be
lost after menopause with a significant decrease in HDL-C [25].
Although the mechanisms underlying the relationship between
vitamin D status and dyslipidemia are not well known, one animal
study reported that the plasma vitamin D concentration was
positively associated with HDL-C (p=0.003), concluding that
lower vitamin D would be associated with a more atherogenic lipid
profile, which is a major risk factor for progression toward
coronary artery atherosclerosis [26]. In a process called reverse
cholesterol transport, large HDL particles are known to carry
cholesterol from atherosclerotic plaques [27], and these large HDL
particles are driven from cholesterol-loaded macrophages by
cholesterol efflux that it is vitamin D which regulates macrophage
function [28].
Our result showed that elevated blood pressure was statistically
significantly related with vitamin D status in postmenopausal
Korean women. Similar results have been found in many clinical
studies [29,30]. Vitamin D receptors are distributed on vascular
smooth muscle, endothelium, cardiomyocytes, and activated 1,25-
dihydroxyvitamin D suppresses renin gene expression, regulating
the growth and proliferation of vascular smooth muscle cells,
cardiomyocytes, and inhibiting cytokine release from lymphocytes.
Therefore, the absence of vitamin D receptor activation leads to
tonic upregulation of the renin-angiotensin system, eventually
leading to hypertension and left ventricular hypertrophy [31].
However, despite strong physiological evidence, some studies
Table 2. Metabolic syndrome and its risk factors of
postmenopausal participants compared by vitamin D status
(n = 4364).
Serum 25(OH)D
Group 1 Group 2 Group 3 p-value
WC (cm) 82.669.6 82.469.0 82.169.3 0.375
Abdominal
obesity
564 (38.8) 553 (38.0) 552 (38.0) 0.872
SBP (mmHg) 127.5618.8 127.2618.2 125.9618.0 0.044
DBP (mmHg) 77.4610.1 77.9610.2 76.969.9 0.020
Elevated BP or
medication
905 (62.2) 871 (59.8) 850 (58.5) 0.108
FPG (mg/dL) 101.5625.7 100.9624.9 100.5622.6 0.520
Elevated FPG or
medication
547(37.6) 501 (34.4) 515 (35.4) 0.182
TGs (mg/dL) 143.2688.4 137.1688.2 131.6680.2 0.001
Elevated TGs or
medication
596 (41.0) 542 (37.2) 532 (36.6) 0.031
HDL-C (mg/dL) 51.3612.4 52.4612.3 52.7612.7 0.005
Reduced HDL-C or
medication
801 (55.1) 725 (49.8) 722 (49.7) 0.004
Metabolic
syndrome
498 (34.3) 453 (31.1) 460 (31.6) 0.153
Data are presented as mean 6 standard deviation; numbers (%).
Abbreviations: WC, waist circumference; SBP, systolic blood pressure; DBP,
diastolic blood pressure; BP, blood pressure; FPG, fasting plasma glucose; TGs,
triglycerides; HDL-C, high-density lipoprotein cholesterol.
doi:10.1371/journal.pone.0089721.t002
Table 3. Odds ratio of metabolic syndrome and its components by serum 25(OH)D levels in postmenopausal women (n = 4364).
Serum 25(OH)D
Group 1 Group 2 Group 3 p for trends1 p-value{
1445 1445 1446
Metabolic syndrome 1.0 0.91 (0.77–1.06) 0.90 (0.76–1.05) 0.333 0.165
Abdominal obesity 1.0 0.98 (0.84–1.14) 0.95 (0.82–1.11) 0.825 0.538
Elevated BP 1.0 0.95 (0.81–1.12) 0.83 (0.71–0.98) 0.066 0.020
Elevated fasting glucose 1.0 0.89 (0.76–1.04) 0.90 (0.77–1.06) 0.288 0.259
Elevated TGs 1.0 0.87 (0.75–1.01) 0.83 (0.71–0.97) 0.043 0.014
Reduced HDL-C 1.0 0.84 (0.72–0.97) 0.80 (0.69–0.93) 0.010 0.002
Data are presented as OR (95% CI).
1Values from comparisons of metabolic syndrome and its components among tertiles of 25(OH)D.
{Values from comparisons of metabolic syndrome and its components in between the lowest and highest tertiles of 25(OH)D.
Abbreviations: OR, odds ratio; CI, confidence interval; TGs, triglycerides; HDL-C, high-density lipoprotein cholesterol.
Adjusted for age, seasonality, occupation, education, alcohol, smoking, physical activity, and HT.
doi:10.1371/journal.pone.0089721.t003
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evaluating the association between serum levels of 25(OH)D and
blood pressure have presented contradictory findings [32,33].
Natural menopause is known to be associated with increased
central adiposity [24]; further, in cases of similar mean BMI values
for premenopausal and postmenopausal women, increased WC
has been found to be significantly associated with postmenopausal
status after adjusting for age [20]. A previous study reported that
serum 25(OH)D levels were negatively associated with WC [34].
In our study, WC, the prevalence of abdominal obesity, and the
OR for prevalence of abdominal obesity related to vitamin D
increased as tertiles of 25(OH)D decreased; however, these results
were not statistically significant. This could possibly be explained
by a cultural tendency in Korean women, who are sensitive about
their appearance and make the effort to maintain their physical
appearance. Further, elevated FPG was not found to be related
with serum levels of 25(OH)D, possibly because the overall plasma
glucose level in this population was low.
As the numbers of UV photons reaching the earth’s surface vary
markedly by the time of the day and the season, vitamin D
production in the skin decreases in the early morning, late
afternoon, and during winter [17]. Although South Korea is
located at the latitudes of 33–38,u which receive adequate
numbers of UVB photons for synthesizing vitamin D [17], we
have found a high prevalence of vitamin D deficiency in South
Korean postmenopausal women, which could be explained by
increased indoor activity and the use of sunscreens and other sun
protectors. Since cutaneous vitamin D production in elderly
individuals is known to diminish [35], it is easy to assume that the
prevalence of vitamin D deficiency in women with older age would
be higher. However, our results demonstrated that the prevalence
of vitamin D deficiency was not directly proportional with age.
This finding could be explained by an age-related decline in
kidney function. A previous study in rats reported that as kidney
function declines, so does 1,25(OH)2D production [28] as well as
the metabolic clearance of 25(OH)D. Therefore, although vitamin
D production in the skin decreases with age, so does the utilization
of 25(OH)D in the kidney; therefore, these effects negate each
other such that the serum levels of 25(OH)D are not greatly
affected.
This study has several strengths. First, the study was performed
using a representative sample of the general South Korean
population. Second, rigorous quality controls were applied to the
study procedures in KNHANES. Third, the exclusion of women
who had undergone a hysterectomy reduced some bias because a
certain proportion of such subjects might not have an accurate
menopausal status. However, our study has certain limitations.
First, because it is a cross-sectional study, direct associations
between the variables of interest could not be determined. Second,
we could not consider factors such as amounts of sunlight
exposure, calcium intake, and vitamin D intake – which could
have affected the serum levels of 25(OH)D – because of the limited
data. Further, measurements were performed only once for each
participant, and serial measurements over a year would be
required for more accurate studies.
In summary, vitamin D deficiency was found to be common in
South Korean menopausal women, showing a strong seasonal
effect. Further, serum 25(OH)D levels were not significantly
correlated with the prevalence of metabolic syndrome in
postmenopausal women; however, elevated BP, elevated TG,
and reduced HDL-C levels were found to decrease significantly as
the serum levels of 25(OH)D increased. These findings demon-
strate that metabolic syndrome is not entirely dependent upon its
five components and is likely affected by other factors such as
abnormalities in molecular pathophysiology, which are correlated
with the prevalence of metabolic syndrome. Further investigations
regarding these aspects would clarify such underlying factors.
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